Alzex Neuropharma Inc. (TRRI)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Feb 6, 2026
Alzex Neuropharma Market Cap
Alzex Neuropharma has a market cap or net worth of $452.00 as of March 6, 2026. Its market cap has decreased by -99.94% in one year.
Market Cap
452.00
Enterprise Value
n/a
Revenue
4.73M
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since July 14, 2008, Alzex Neuropharma's market cap has decreased from 60.00K to 452.00, a decrease of -99.25%. That is a compound annual growth rate of -24.28%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RegeneRx Biopharmaceuticals | 453.00 |
| Tetra Bio-Pharma | 516.00 |
| Mera Pharmaceuticals | 537.00 |
| Adynxx | 581.00 |
| Eloxx Pharmaceuticals | 330.00 |
| Amarantus BioScience Holdings | 630.00 |
| Predictive Technology Group | 317.00 |
| Nabriva Therapeutics | 646.00 |